Geron Q3 revenue beats forecast on strong RYTELO demand, initiates EU launch
Geron reported $60.1M net product revenue, up 10% QoQ, and reiterated a high-end revenue guidance of $240M. The company announced a gated commercial launch in European markets to expand patient access.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed